Skip to main navigation Skip to search Skip to main content

Ethical issues in intervention studies on the prevention and management of diabetes and hypertension in sub-Saharan Africa

  • Elizabeth Shayo
  • , Marie Claire Van Hout
  • , Josephine Birungi
  • , Anupam Garrib
  • , Sokoine Kivuyo
  • , Sayoki Mfinanga
  • , Moffat J. Nyrienda
  • , Ivan Namakoola
  • , Joseph Okebe
  • , Kaushik Ramaiya
  • , Max Oscar Bachmann
  • , Walter Cullen
  • , Jeffrey V. Lazarus
  • , Geoff Gill
  • , Tinevimbo Shiri
  • , Dominic Bukenya
  • , Hazel Snell
  • , Mastula Nanfuka
  • , Luis E. Cuevas
  • , Meshack Shimwela
  • Gerald Mutungi, Joshua Musinguzi, Janneth Mghamba, Kenneth Mugisha, Shabbar Jaffar, Peter G. Smith, Nelson Kaulukusi Sewankambo

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)
15 Downloads (Pure)

Abstract

Conducting intervention studies in Africa, where medicines supply for chronic conditions is inequitable and patchy, raises major ethical issues.

Here we discuss what should the ethical approach be for a research programme in terms of provision of a steady and sustainable supply of medicines for patients with diabetes and hypertension.
Original languageEnglish
Article numbere002193
JournalBMJ Global Health
Volume5
Issue number7
Early online date6 Jul 2020
DOIs
Publication statusPublished - 6 Jul 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this